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Abstract: Microcystins are hepatotoxic cyclic peptides produced by several cyanobacterial 
genera worldwide. In 2008, our research group identified eight new glycine-containing 
microcystin congeners in two hydro-terrestrial mat samples from the McMurdo Dry Valleys 
of Eastern Antarctica. During the present study, high-resolution mass spectrometry, amino 
acid analysis and micro-scale thiol derivatization were used to further elucidate their 
structures. The Antarctic microcystin congeners contained the rare substitution of the position-1 
D-alanine for glycine, as well as the acetyl desmethyl modification of the position-5 Adda 
moiety (3S-amino-9S-methoxy-2S,6,8S-trimethyl-10-phenyldeca-4E,6E-dienoic acid). Amino 
acid analysis was used to determine the stereochemistry of several of the amino acids and 
conclusively demonstrated the presence of glycine in the microcystins. A recently developed 
thiol derivatization technique showed that each microcystin contained dehydrobutyrine in 
position-7 instead of the commonly observed N-methyl dehydroalanine. 
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1. Introduction 
The McMurdo Dry Valleys in Eastern Antarctica form the largest ice-free region in Antarctica and 
are characterized by low temperatures, minimal precipitation and strong winds [1]. Despite these harsh 
conditions, life is still present in this arid environment in the form of microbial communities [2–4]. 
Cyanobacteria proliferate in the moist areas in and around glacial streams and lakes and form thick 
benthic mats [5–7]. Many cyanobacteria genera around the world have been reported to produce 
hepatotoxic microcystins (MCs) [8], and this is also the case for cyanobacterial communities that grow 
in the harsh climates of the Arctic and Antarctica [9–13]. 
Microcystins are a family of cyclic heptapeptides produced by a combination of non-ribosomal 
peptide synthetase and polyketide synthase modules. As observed in MC-LR (1) and MC-RR (2; Figure 1), 
microcystins contain L-amino acids, D-amino acids and more unconventional amino acids, such as; Adda  
(3S-amino-9S-methoxy-2S,6,8S-trimethyl-10-phenyldeca-4E,6E-dienoic acid) or N-methyl dehydroalanine 
(Mdha). To date, there have been at least 100 different microcystin congeners characterized [14], mostly 
due to substitutions of the variable L-amino acids in positions-2 and -4, although modifications have 
been reported for all of the amino acids [15]. Substitution of the position-1 D-alanine is uncommon, and 
only substitutions for D-serine [16], D-leucine (Leu) [17,18] and methionine [19,20] have been  
reported to date. 
 
Figure 1. Structures of microcystin-LR (1) and microcystin-RR (2), where Adda is  
3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid, Mdha is N-methyl 
dehydroalanine and Masp is methylaspartic acid. 
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In 2008, our research group showed that microcystin-producing cyanobacteria were particularly 
prolific in the McMurdo Dry Valleys of Antarctica. Each sample collected tested positive for at least 
low levels of microcystin [21]. Previously, only [Asp3] MC-LR, MC-LR and nodularin had been reported 
in Antarctic cyanobacteria [9–11], but our 2008 study also identified [Asp3, Dha7] MC-LR, MC-FR and 
MC-RR, including its [Asp3] and [Asp3, Dha7] congeners [21]. During the course of this study,  
a discrepancy between different methods of determining microcystin content was noted in several 
samples. Whilst a high concentration of microcystin was detected using an enzyme-linked immunosorbent 
assay and protein phosphatase inhibition assay, only low concentrations of some common microcystins 
were detected by liquid chromatography-tandem mass spectrometry (LC-MS/MS). Further investigation 
demonstrated that these samples contained eight new microcystins, which were not initially detected by 
the LC-MS/MS multiple reaction monitoring method. 
The new microcystins contained several interesting structural modifications; the presence of 
homoarginine (Har) residues, acetylation of the Adda moiety (ADM Adda; acetyl desmethyl Adda) and 
substitution of the position one amino acid for glycine (Gly). The presence of these new microcystins 
was reported in the 2008 paper, and their structures were postulated based on the daughter ion spectra. 
Here, we present more in-depth characterization of these compounds and further clarification of  
their structures. 
 
Figure 2. Positive ion matrix-assisted laser desorption/ionization-time of flight mass spectra 
of the two Miers Valley (Antarctica) samples of (a) MVAG1 and (b) MVMG1. 
2. Results and Discussion 
2.1. Oligopeptide Diversity in the Miers Valley Cyanobacterial Mats 
Methanol extracts of two samples (Sample IDs: MVAG1 and MVMG1) collected from Miers Valley, 
Antarctica, were analysed by matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) 
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MS. The positive ion mass spectra (Figure 2) and post-source decay (PSD) experiments indicated the 
presence of two groups of oligopeptides; six linear peptides with masses between 800 and 844 Da and 
eight microcystins between 966 and 1,051 Da. The linear peptides appear to consist of an ester-linked 
hydroxyphenyllactic acid C-terminus, two aromatic amino acids, isoleucine or leucine and an unusual 
168-Da moiety at the N-terminus [22]. Further structural characterization of these new compounds 
remains a focus of our research group. 
2.2. Structural Characterization of Eight Glycine-Containing Microcystins 
Analysis of the Miers Valley samples by LC-MS suggested that they contained four structural variants 
of MC-LR (referred to as Antarctic-LR congeners; Figure 3) and four variants of MC-RR (referred to as  
Antarctic-RR congeners), as these compounds were eluted from a reversed-phase C18 column within the 
appropriate retention regions (Table 1). Whilst the compounds possessed protonated ions that matched 
those of previously described microcystins, the MS/MS spectra indicated that all eight microcystins were 
new [21]. A combination of amino acid analysis, chemical derivatization and MS data was used to 
confirm the putative structures for 3–10. 
 
Figure 3. Structures of the eight Antarctic microcystin (MC) congeners (3–10) identified 
from two Miers Valley (Antarctica) samples; Arg, arginine; Dhb, dehydrobutyrine;  
Gly, glycine; Har, homoarginine; Leu, Leucine. 
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Table 1. Molecular masses and retention times of the eight Antarctic microcystin congeners 
(3–10) identified from two Miers Valley (Antarctica) samples and two common microcystin 
congeners (1–2). 
Microcystin 
Mr 
a  
(Da) 
RT b  
(min) 
MC-LR (1) 994.5 7.40 
[Gly1, Asp3, Dhb7] MC-LR (3) 966.5 7.27 
[Gly1, Asp3, Dhb7] MC-LHar (4) 980.5 7.34 
[Gly1, Asp3, ADMAdda5, Dhb7] MC-LR (5) 994.5 7.29 
[Gly1, Asp3, ADMAdda5, Dhb7] MC-LHar (6) 1008.5 7.36 
MC-RR (2) 1023.6 6.48 
[Gly1, Asp3, Dhb7] MC-RR (7) 1009.6 6.29 
[Gly1, Asp3, Dhb7] MC-RHar (8) 1023.6 6.38 
[Gly1, Asp3, ADMAdda5, Dhb7] MC-RR (9) 1037.6 6.33 
[Gly1, Asp3, ADMAdda5, Dhb7] MC-RHar (10) 1051.6 6.42 
a Molecular weights are rounded to one decimal place; b RT = retention time on a C18 column as per [23]. 
As only a small amount of algal extract was available, fractionation of the new microcystins did not 
proceed beyond isolating two fractions containing a mixture of the four Antarctic-LR congeners and a 
mixture of the four Antarctic-RR congeners. High resolution mass spectrometry (HRMS) analysis was 
conducted on these semi-pure mixtures of the Antarctic microcystin congeners and gave mass-to-charge 
ratios consistent with the singly-protonated ions for structures 3–10 and mass deviations of less than  
4 ppm (Supplementary Information Table S1). The accurate masses for 5–6 and 9–10 indicated that the 
28-Da mass increase observed in the position-5 amino acid of these compounds was due to an additional 
carbonyl (ADMAdda), rather than two additional methyl groups. 
Each mixture of four microcystins was also hydrolyzed and subjected to Advanced Marfey’s amino 
acid analysis [24,25] to determine the amino acids present and their stereochemistry. Liquid 
chromatography-MS analysis of the L-1-fluoro-2,4-dinitrophenyl-5-leucine (FDLA) derivatives of the 
hydrolysed Antarctic-LR congeners (Supplementary Information Figure S1) and comparison with 
standard amino acids (Supplementary Information Figure S2) confirmed the presence of D-aspartic acid 
(Asp; m/z 426; 12.9 min), D-glutamic acid (Glu; m/z 440; 14.3 min), Gly (m/z 368; 15.2 min) and L-Leu 
(m/z 424; 21.0 min). Comparison with the L-FDLA derivatives of hydrolysed MC-LR (Supplementary 
Information Figure S3) indicated the presence of 3(S)-Adda (m/z 592; 32.9 min) [25]. Amino acid 
analysis of the Antarctic-RR congeners revealed similar results (Supplementary Information Figure S4); 
the presence of D-Asp (m/z 426; 12.9 min), D-Glu (m/z 440; 14.3 min), Gly (m/z 368; 15.2 min) and  
3(S)-Adda (m/z 592; 32.9 min). 
N-Methylamine (m/z 324; 19.6 min; Supplementary Information Figure S3) was not observed in the 
amino acid analysis of the Antarctic microcystin mixtures, but is commonly observed during microcystin 
analysis [25], as it is the product of the hydrolytic breakdown of Mdha. A micro-scale thiol derivatization 
was used to verify the absence of Mdha in the Antarctic microcystin congeners. A microcystin containing 
a terminal alkene, such as that in Mdha or dehydroalanine (Dha), will readily react with β-mercaptoethanol 
under alkaline conditions [26,27]. Monitoring of the derivatization by LC-MS showed that MC-LR, 
which contains Mdha, reacted quickly with β-mercaptoethanol (t½ = 4.8 min; Figure 4a). A reaction rate 
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that was approximately twice as fast was observed with a microcystin containing two arginine residues 
(MC-RR; t½ = 2.6 min; Figure 4c). However, with a microcystin containing dehydrobutyrine (Dhb), the 
reaction rate was hundreds of times slower [28]. When the Antarctic-LR congeners were derivatized 
with β-mercaptoethanol, the reaction rate was over two orders of magnitude slower than that of MC-LR  
(t½ = 1,089 min; Figure 4b). A similar difference in reaction rate was observed with the Antarctic-RR 
congeners when compared to MC-RR (t½ = 632 min; Figure 4d). The slow reaction rate with  
β-mercaptoethanol, in combination with the absence of N-methylamine in the amino acid analysis, gives 
a strong indication that the Antarctic microcystin congeners contained dehydrobutyrine (Dhb) instead of 
Mdha/Dha. This substitution could also be confirmed by analysis for the 2-ketobutyric acid produced 
from the hydrolytic breakdown of Dhb [29]; however, there was insufficient material to conduct these 
additional analyses. The presence of Dhb was unable to be confirmed during the 2008 study [21],  
when this amino acid was tentatively assigned as Mdha. 
 
Figure 4. Time courses and first-order rate plots (inset) for the β-mercaptoethanol 
derivatization (at 30 °C; pH 9.7) of: (a) MC-LR; (b) the Antarctic-LR congeners identified 
in two Miers Valley (Antarctica) samples; (c) MC-RR; and (d) the Antarctic-RR congeners 
identified in two Miers Valley samples. 
 
Figure 5. Tandem mass spectrometry fragments commonly observed in (a) Adda-containing 
microcystins and (b) in ADMAdda-containing microcystins. 
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Figure 6. Electrospray ionization collision-induced dissociation tandem mass spectra for  
3–6 (a–d) and the putative structures of the microcystins. 
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The Adda portion of the microcystin structure fragments under electrospray ionization collision-induced 
dissociation (ESI CID) conditions to form diagnostic ions (m/z 135 and 163; Figure 5a) commonly used 
for the identification and characterization of microcystins [30,31]. Microcystins containing the 
ADMAdda modification form different fragment ions under ESI CID conditions (m/z 60 and 265;  
Figure 5b) as the O-acetyl group dissociates from the main structure more readily [32]. 
The ESI CID MS/MS spectrum of 3 indicated that the compound contained Adda, as an intense  
m/z 135 fragment ion was present (Figure 6a) The m/z 112, 129 and 157 ions indicated that the 
microcystin contained an arginine (Arg) residue [33]. The later retention time on reversed-phase C18 
(Table 1) suggested that it was unlikely that there were two Arg residues present. The mass difference 
between the fragment ions indicated the position of the remaining amino acids in the compound  
(Table 2). 
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Table 2. Tandem mass spectrometry fragment assignments for MC-LR (1) and 3–6 observed by electrospray ionization collision-induced dissociation. 
Fragment Assignment a 
MC-LR b  
(1) 
[Gly1, Asp3, Dhb7]  
MC-LR (3) 
[Gly1, Asp3, Dhb7]  
MC-LHar (4) 
[Gly1, Asp3, ADMAdda5, Dhb7]  
MC-LR (5) 
[Gly1, Asp3, ADMAdda5, Dhb7]  
MC-LHar (6) 
M + H 995.6 967.6 981.6 995.6 1,009.6 
M − HOAc + H - - - 935.5 949.3 
(Me)Asp-Arg/Har-(ADM)Adda-Glu-Mdha/Dhb-Gly/Ala + H 882  868.6  896.9 
Arg/Har-(ADM)Adda-Glu-Mdha/Dhb-Gly/Ala + H 753  753.3  781.4 
(Me)Asp-Arg/Har-(ADM)Adda-Glu + H 728  728.4  756.4 
Arg/Har-(ADM)Adda-Glu-Mdha/Dhb + H 682 682.5 696.1 710.3 724.3 
Glu-Mdha/Dhb-Gly/Ala-Leu-(Me)Asp-Arg/Har + H 682  668.0   
Arg/Har-(ADM)Adda-Glu + H 599 599.3 613.2 627.2 641.4 
(Me)Asp-Arg/Har-(ADM)Adda + H 599    627.3 
(ADM)Adda’-Glu-Mdha/Dhb-Gly/Ala-Leu + H 559  545.4   
Mdha/Dhb-Gly/Ala-Leu-(Me)Asp-Arg/Har + H 553 525.2 539.4 525.2 539.3 
Glu-Mdha/Dhb-Gly/Ala-Leu-(Me)Asp + H 526   498.2  
Arg/Har-(ADM)Adda + H 470    512.3 
Gly/Ala-Leu-(Me)Asp-Arg/Har + H 470 442.3 456.2 442.1 456.1 
(ADM)Adda’-Glu-Mdha/Dhb-Gly/Ala + H 446 432.2 432.1   
Leu-(Me)Asp-Arg/Har + H 399 385.1 399.1 385.4  
Glu-Mdha/Dhb-Gly/Ala-Leu + H 397   383.1 383.1 
(ADM)Adda'-Glu-Mdha/Dhb + H 375 375.1 375.2 375.2  
Mdha/Dhb-Gly/Ala-Leu-(Me)Asp + H 397   369.2  
(ADM)Adda'-Glu + H 292 292.1 292.2 292.1 292.1 
Gly/Ala-Leu-(Me)Asp + H 314  286.1 286.3 286.1 
ADMAdda − HOAc + H - - - 282.2 282.2 
ADMAdda − HOAc − NH3 + H - - - 265.1 265.2 
(Me)Asp-Arg/Har + H 286 272.1 286.1 272.1 286.1 
Glu-Mdha/Dhb-Gly/Ala + H 284 270.2 270.2 270.1 270.2 
Mdha/Dhb-Gly/Ala-Leu + H 268 254.3 254.1 254.1 254.1 
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Table 2. Cont. 
Fragment Assignment a 
MC-LR b  
(1) 
[Gly1, Asp3, Dhb7]  
MC-LR (3) 
[Gly1, Asp3, Dhb7]  
MC-LHar (4) 
[Gly1, Asp3, ADMAdda5, Dhb7]  
MC-LR (5) 
[Gly1, Asp3, ADMAdda5, Dhb7]  
MC-LHar (6) 
Leu-(Me)Asp + H 243  229.2 229.0 229.1 
Glu-Mdha/Dhb + H 213 213.1 213.1 213.1 213.1 
Gly/Ala-Leu + H 185 171.0 171.1 171.0 171.1 
(ADM)Adda' + H 163 163.1 163.1 163.1 163.0 
Arg/Har + H 157 157.0 171.1 157.1 171.1 
Mdha/Dhb-Gly/Ala + H 155 141.0 141.0 141.1 141.1 
(ADM)Adda sidechain 135 135.1 135.1 163.1 163.0 
Arg/Har immonium 129 129.2 143.1 129.1 143.1 
Arg/Har fragment 112 112.1 112.0/126.1 112.0 111.9/126.1 
a Fragments containing CO losses and NH4+ adducts were not included; Adda’ = Adda minus NH2 and the sidechain (C9H11O or C10H11O2); b m/z values for MC-LR fragments 
are theorized nominal values [34–36]. 
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The fragment ion series beginning with the Adda’ fragment (Adda minus NH2 and C9H11O; m/z 163; 
Figure 5a) indicated that 3 contained Glu and Dhb in positions six and seven, respectively (Figure 7a). 
The m/z 432 ion extended this ion series to include a Gly in position-1, yielding a sequence of  
Adda-Glu-Dhb-Gly. Another fragment ion series, which began with Arg (m/z 157), extended to include 
Asp, Leu, Gly, Dhb and Glu (Figure 7b). This gave a sequence of Arg-Asp-Leu-Gly-Dhb-Glu, the end 
of which overlapped with the previous sequence, resulting in a complete peptide sequence of  
Adda-Glu-Dhb-Gly-Leu-Asp-Arg. The m/z 599 ion (Arg-Adda-Glu) indicated that the Arg was joined 
to Adda and that the structure was cyclic (Figure 7c). The m/z 126, 143 and 171 ions in the MS/MS 
spectrum for 4 (Figure 6b) suggested that the microcystin contained a homoarginine (Har). Assignment 
of the daughter ions (Table 2) placed the Har residue in position-4. 
 
Figure 7. Tandem mass spectrometry fragment ions yielding three amino acid sub-sequences 
(a–c) which indicate the full amino acid sequence for [Gly1, Asp3, Dhb7] MC-LR (3). 
The MS/MS spectrum for 5 (Figure 6c) did not contain an intense m/z 135 fragment ion. However,  
a loss of 60 Da (HOAc) was evident, which indicated that 5 contained an O-acetyl group. The m/z 265 
ion suggested that this was due to an O-acetyl group on the Adda moiety (ADMAdda; Figure 4b) [37]. 
As with 3, it was likely that a single Arg residue was present in this microcystin. Comparison of the 
MS/MS spectrum with that of 3 indicated that much of the structure for 5 was the same (Table 2),  
apart from the inclusion of ADMAdda in position-5. The MS/MS spectrum for 6 (Figure 6d) indicated 
that the structure was similar to 5, except that the position-4 amino acid was Har. 
The daughter ion spectrum for 7 (Figure 8a) contained an intense m/z 135 fragment ion, suggesting 
the presence of Adda. The m/z 112, 129 and 157 ions in the spectrum indicated that 7 contained an Arg 
residue. However, the earlier retention time on C18 (Table 1) and loss of 42 Da (CN2H2) in the MS/MS 
spectrum suggested that there were two Arg residues present [35]. Comparison with the MS/MS 
spectrum for 3 indicated that much of the structure was very similar, except that the Leu at position-2 
had been replaced with Arg (Table 3). The fragment ions for 8 (Figure 8b) showed that the compound 
was similar to 7, except that the position-4 amino acid was Har. 
The MS/MS spectrum for 9 did not contain an intense m/z 135 fragment ion, but the presence of 
ADMAdda was suggested by the m/z 265 fragment and a loss of 60 Da (Figure 8c). As with 7,  
Toxins 2015, 7 504 
 
 
the inclusion of two Arg residues was indicated by diagnostic ions (m/z 112, 129 and 157) and the earlier 
retention time on reversed-phase C18 (Table 1). Comparison with the MS/MS spectrum for 7 indicated 
that much of the structure for 9 was the same, apart from the inclusion of ADMAdda at position-5 (Table 3). 
Likewise, 10 (Figure 8d) was structurally similar to 9, except that Har was present in position-4. 
 
Figure 8. Electrospray ionization collision-induced dissociation tandem mass spectra for  
7–10 (a–d) and the putative structures of the microcystins. 
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Table 3. Tandem mass spectrometry fragment assignments for MC-RR (2) and 7–10 observed by electrospray ionization  
collision-induced dissociation. 
Fragment Assignment a 
MC-RR b  
(2) 
[Gly1, Asp3, Dhb7] 
MC-RR (7) 
[Gly1, Asp3, Dhb7] 
MC-RHar (8) 
[Gly1, Asp3,  
ADMAdda5, Dhb7]  
MC-RR (9) 
[Gly1, Asp3, 
ADMAdda5, Dhb7] 
MC-RHar (10) 
M + H 1024.7 1010.7 1024.7 1038.7 1052.7 
M − CN2H2 + H 982 968.9 982.5 996.5 1010.8 
M − HOAc + H - - - 978.6 992.5 
Arg/Har-(ADM)Adda-Glu-Mdha/Dhb-Gly/Ala-Arg + H 909 895.3 909.6   
(Me)Asp-Arg/Har-(ADM)Adda-Glu-Mdha/Dhb-Gly/Ala + H 882  868.6  896.4 
(Me)Asp-Arg/Har-(ADM)Adda-Glu-Mdha/Dhb + H 811  811.5 825.1 839.8 
Arg/Har-(ADM)Adda-Glu-Mdha/Dhb-Gly/Ala + H 753 739.2 753.4  781.0 
(Me)Asp-Arg/Har-(ADM)Adda-Glu + H 728 714.3 728.3 742.1 756.2 
Arg/Har-(ADM)Adda-Glu-Mdha/Dhb + H 682 682.2  710.2 724.2 
Glu-Mdha/Dhb-Gly/Ala-Arg-(Me)Asp-Arg + H 725 697.5  697.3  
Arg/Har-(ADM)Adda-Glu + H 599  613.5  641.2 
(Me)Asp-Arg/Har-(ADM)Adda + H 599 585.2 599.2 613.4 627.9 
Mdha/Dhb-Gly/Ala-Arg-(Me)Asp-Arg/Har + H 596  582.4 568.7  
Har-ADMAdda − HOAC + H - - -  452.5 
(ADM)Adda'-Glu-Mdha/Dhb-Gly/Ala + H 446 432.2    
Glu-Mdha/Dhb-Gly/Ala-Arg + H 440 426.4  426.2  
Mdha/Dhb-Gly/Ala-Arg-(Me)Asp + H 440 412.1 412.3 412.2 412.3 
(ADM)Adda'-Glu-Mdha/Dhb + H 375 375.1 375.2   
Gly/Ala-Arg-(Me)Asp + H 357 329.1  329.1 329.1 
Mdha/Dhb-Gly/Ala-Arg + H 311 297.1 296.9 297.0 297.0 
(ADM)Adda'-Glu + H 292   292.1  
ADMAdda − HOAc + H - - - 282.3 282.1 
ADMAdda − HOAc − NH3 + H - - - 265.4 265.3 
(Me)Asp-Arg/Har + H 286 272.3 286.2  286.1 
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Table 3. Cont. 
Fragment Assignment a 
MC-RR b  
(2) 
[Gly1, Asp3, Dhb7] 
MC-RR (7) 
[Gly1, Asp3, Dhb7] 
MC-RHar (8) 
[Gly1, Asp3, 
ADMAdda5, Dhb7] 
MC-RR (9) 
[Gly1, Asp3, 
ADMAdda5, Dhb7] 
MC-RHar (10) 
Arg-(Me)Asp + H 286 272.3 272.1 272.2 272.5 
Glu-Mdha/Dhb-Gly/Ala + H 284 270.0  270.1  
Gly/Ala-Arg + H 228 214.1 214.0 214.1 214.2 
Glu-Mdha/Dhb + H 213 213.1 212.9 213.1 213.2 
(ADM)Adda' + H 163 163.0 162.9 163.0  
Har + H - -  - 171.0 
Arg + H 157 157.0 157.1 156.6 156.9 
Mdha/Dhb-Gly/Ala + H 155 141.5 140.9 141.2 140.7 
(ADM)Adda sidechain 135 135.1 135.1 163.0  
Har immonium - - 143.1 - 143.1 
Arg immonium 129 129.5 129.1 129.1  
Har fragment - - 112.0/126.0 - 111.8/125.8 
Arg fragment 112 112.2 112.0 112.1 111.8 
a Fragments containing CO losses and NH4+ adducts were not included; Adda’ = Adda minus NH2 and the sidechain (C9H11O or C10H11O2); b m/z values for MC-RR fragments 
are theorized nominal values [31,35]. 
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The LC-MS/MS assignments for the Antarctic microcystin congeners were consistent with previous 
analyses of low-energy, collision-activated spectra from similar microcystin variants [32,38–40]. Whilst 
the glycine substitution in position-1 is novel, the fragment ion series observed were similar to those 
reported for other microcystin congeners containing a position-1 substitution [16,17]. In several of the 
spectra, low-intensity m/z 155 (Mdha/Dhb-Ala) and m/z 135 (Adda sidechain fragment) ions were 
present along with the predominant ADMAdda congener ions. This was possibly due to the presence of 
small amounts of MC-LR and MC-RR in the concentrated extracts, as the contaminant ions were present 
at much lower intensities than would be expected. Furthermore, in each of the spectra containing these 
ions, the contaminant ion series do not continue further than these two easily-formed low-mass ions. 
Each of the new microcystins contained a D-Asp in position-3, which has been frequently  
observed in multiple cyanobacterial genera, including Anabaena [41], Microcystis [30], Nostoc [42], 
Oscillatoria [43] and Planktothrix [44], as well as cyanobacteria from Antarctica [11]. The position-7 
Dhb has been reported in at least 15 other microcystins [43–49], three of which were ADMAdda-containing 
microcystins [46]. However, the frequency of the occurrence of Dhb-containing microcystins is 
potentially underestimated, as many microcystin congeners have been characterized solely by MS/MS. 
This does not allow for discrimination between the isometric Mdha and Dhb. The micro-scale thiol 
derivatization [28] utilized in this work will be of great utility to confirm the identity of the position-7 
amino acid in microcystins where the sample size is limited. 
The position-1 alanine in microcystins is highly conserved, but substitutions for leucine, serine and 
methionine have been reported [16–20]. However, prior to our 2008 study [21], a substitution for glycine 
had not been observed, although the adenylation domain responsible for incorporating the position-1 
amino acid in microcystins (McyA2) shows structural similarity to the saframycin synthetase glycine 
adenylation domain [50,51]. 
Substitution of Arg for Har is rare, with only five microcystin congeners containing this amino  
acid being characterized to date [35,42,48,52,53]. Two further microcystins have been identified as 
containing Har, but full structures have not been reported [38]. At least thirteen ADMAdda-containing 
microcystins have been reported [16,37,39,42,46,52,54] from Nostoc and Planktothrix species from 
across Europe. Although the cyanobacterial strain responsible for the production of the new Antarctic 
microcystins was not isolated and cultured, molecular investigations identified the microcystin-producing 
cyanobacterium to be of the genus Nostoc [21]. 
The MS/MS analysis indicated the presence of Arg in six of the microcystins and Har in four of the 
microcystins. The amino acid analysis protocol used had poor sensitivity for arginine-like residues, and 
with the small sample size available, these amino acids were not detected. The MS/MS analysis also 
suggested that four of the microcystins contained ADMAdda. It is highly probable that ADMAdda would 
lose the O-acetyl group in the same manner as the O-methyl group of Adda is lost during acid  
hydrolysis [25,46]; hence, the two moieties would form the same hydroxylated product. 
The small sample size available (<50 µg of each congener) prevented purification of the Antarctic 
microcystin congeners from proceeding beyond the separation of two mixtures containing the 
Antarctic-LR congeners and the Antarctic-RR congeners from the other components in the extract. 
Therefore, no bioactivity screening was conducted. Other microcystins containing similar modifications 
to these new congeners have been shown to be relatively potent in the mouse bioassay [46,52]. 
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The identification of eight microcystin congeners containing uncommon modifications (glycine in 
position-1, homoarginine residues and ADMAdda modifications) was a significant discovery when first 
reported in 2008 [21]. At the time, it was the first report of ADMAdda-containing microcystins from the 
Southern Hemisphere, and to the best of our knowledge, these are still the only microcystins reported 
that contain glycine. In the present paper, these structures have been further clarified using additional 
analyses that have identified position-7 Dhb moieties in each of the microcystins and determined the 
stereochemistry of several of the amino acids. Although every effort was made to gather as much 
structural information as possible on these new microcystins, the small amount of available material 
precluded purification of individual congeners and nuclear magnetic resonance studies. However,  
the MS data reported here and the amino acid analyses are consistent with the reported structures. 
3. Experimental Section 
3.1. General Experimental Procedures 
MALDI-TOF measurements were made on a AutoFlex II mass spectrometer (Bruker, Ballerica, MA, 
USA). LC-MS and LC-MS/MS analyses were performed on a Bruker AmaZon X ESI ion-trap mass 
spectrometer coupled to an UltiMate 3000 HPLC system (Dionex, Sunnyvale, CA, USA) or a Quattro 
Ultima TSQ triple-quadrupole mass spectrometer (Waters-Micromass, Manchester, UK) coupled to a 
Waters Alliance 2695 HPLC system (Waters Corporation, Millford, DE, USA). HRESIMS was performed 
on a Bruker MicrOTOF mass spectrometer Reversed-phased C18 separations were conducted using 
YMC-gel ODS-A (YMC Corporation, Kyoto, Japan). HPLC purification was performed using Waters 
515 HPLC pumps (Waters Corporation, Millford, DE, USA) coupled to a Waters 2996 photodiode array 
detector (200–400 nm); and a Luna C18 column (150 × 4.6 mm, 5-μm; Phenomenex, Torrance, CA, USA). 
3.2. Sample Collection 
In December, 2006, two hydro-terrestrial cyanobacterial mat samples were collected from Miers 
Valley in the McMurdo Dry Valleys, Antarctica. These samples were obtained from the moist areas in 
front of Adams Glacier (MVAG1; 78°6'36''S, 163°54'20''E) and Miers Glacier (MVMG1; 78°5'42''S, 
163°55'38''E). Microbial mat material was collected with a stainless steel spatula (swabbed with EtOH 
between samples) and placed in sterile 50 mL Falcon tubes. Samples were stored in the dark, below  
0 °C in the field and at −80 °C in the laboratory until analysed. Vouchers of MVAG1 and MVMG1 are 
retained at the Cawthron Institute (Nelson, New Zealand). 
3.3. Matrix-Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry Analysis 
Sample extracts were analysed by MALDI-TOF MS and MALDI PSD as described in Puddick et al., 
2014 [55], using α-cyano-4-hydroxycinnamic acid as a matrix. 
3.4. Liquid Chromatography-Mass Spectrometry Analyses 
Tandem mass spectrometry analyses of the microcystin samples were conducted on a Waters-Micromass 
Quattro Ultima TSQ mass spectrometer (Waters-Micromass, Manchester, UK), as described in  
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Wood et al., 2008 [21]. Thiol derivatization reactions were conducted on a Bruker AmaZon X mass 
spectrometer as described in Puddick et al., 2013 [23]. 
3.5. Isolation of Semi-Pure Mixtures of the Antarctic Microcystins 
Following completion of the 2008 analyses [21], the remaining material of the MVAG1 and MVMG1 
samples was fractionated in order to undertake amino acid analysis and HRMS. MVAG1 (21 g dry weight) 
and MVMG1 (1 g dry weight) were extracted in 70% MeOH (300 mL) by disrupting the cells using an 
ultrasonic bath (35 W; 30 min). After vacuum filtration (#1 filter paper), the remaining cell material was 
re-extracted and filtered four more times. The resulting extract was gravity filtered, concentrated under 
vacuum and dried at 35 °C under a flow of nitrogen. 
The crude extract (51.2 mg) was fractionated by reversed-phase C18 column chromatography (20 g) 
using a steep stepped gradient from water to MeOH to DCM, where 3–10 were eluted between 7:3 and 
9:1 MeOH/H2O. Fractions containing 3–10 were combined (4.1 mg) and separated on a reversed-phase 
C18 column (20 g) using a stepped gradient from water to MeOH, where 3–6 were eluted with  
1:1 MeOH/H2O and 7–10 with 3:2 MeOH/H2O. 
The fraction containing 3–6 (2 mg) was subjected to HPLC using a gradient of water + 0.05% 
trifluoroacetic acid (TFA; A) to ACN + 0.05% TFA (B) at 1 mL/min. The sample was loaded in 10% B, 
which increased to 30% B over 3 min and then to 60% B over the subsequent 13 min, before washing 
with 100% B and re-equilibrating with 10% B. This yielded a mixture of the four Antarctic-LR congeners 
(16 min; 3–6; ≤0.2 mg). The fraction containing 7–10 (1.2 mg) was similarly fractionated by HPLC. The 
sample was loaded in 10% B, which increased to 55% B over 16 min, before washing with 100% B and 
re-equilibrating with 10% B. This yielded a mixture of the four Antarctic-RR (17 min; 7–10; ≤0.2 mg). 
3.6. Advanced Marfey’s Amino Acid Analysis 
Semi-pure mixtures of the four Antarctic-LR congeners and the four Antarctic-RR congeners  
were subjected to amino acid analysis according to the advanced Marfey’s method [24,25].  
1-Fluoro-2,4-dinitrophenyl-5-leucine (FDLA) was synthesized according to the method of Marfey [56], 
but using leucinamide (Bachem, Bubendorf, Switzerland) instead of alaninamide. Both the D- and  
L- forms of the reagent were synthesized from the respective stereoisomers of leucinamide. Microcystin 
mixtures (≤200 µg) were prepared, derivatized and analysed as described in Puddick et al., 2013 [57]. 
Samples were hydrolysed in 6 N HCl (0.5 mL) at 110 °C for 16 h. HCl was removed by drying before 
the hydrolysates were resuspended in H2O (105 µL) and divided into two aliquots (50 µL each). After 
pH adjustment with 1 M NaHCO3 (20 µL), 1% L- or DL-FDLA (w/v; 100 µL) was added, and the samples 
were incubated at 40 °C for 1 h. After being quenched with 1 N HCl (20 µL), the derivatized amino 
acids were diluted with MeOH (810 µL), centrifuged (14,000× g, 5 min) and analysed by LC-MS using 
an Econosil C18 column (250 × 3.2 mm, 5-µ; Alltech, Deerfield, United States of America). Eluting 
derivatives were detected by UV absorption (250–500 nm) and ESI MS (negative ion mode, m/z 300–1100). 
The retention times of the L-FDLA derivatives of standard amino acids were as follows: L-Asp  
(12.2 min), L-Glu (13.5 min), Gly (15.2 min), L-Leu (21.0 min). The retention times of the D-FDLA 
derivatives of standard amino acids were as follows: L-Asp (12.9 min), L-Glu (14.3 min), Gly (15.2 min), 
L-Leu (26.7 min). The retention times of the L-FDLA derivatives were as follows: 3–6: D-Asp (12.9 min), 
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D-Glu (14.3 min), Gly (15.2 min), L-Leu (21.0 min), 3(S)-Adda (32.9 min); 7–10: D-Asp (12.9 min),  
D-Glu (14.3 min), Gly (15.2 min), 3(S)-Adda (32.9 min). 
3.7. β-Mercaptoethanol Derivatization for Mdha/Dhb Determination 
A thiol derivatization technique [28] was used to determine which of the isometric amino acids, Mdha 
or Dhb, was present in the Antarctic microcystins. Standard microcystins (MC-LR and MC-RR) or  
semi-pure mixtures of the Antarctic microcystin congeners were dissolved in methanol (1.42 mL), mixed 
with 200 mM NaHCO3 (pH 9.7; 360 µL) in a septum-capped vial and left to equilibrate at 30 °C. 
Following LC-MS analysis of the original sample, β-mercaptoethanol (20 µL) was added and the vial 
inverted to mix. The reaction mixture was maintained at 30 °C in the sample tray of the LC-MS, and 
injections were made periodically over a 96-h period. 
4. Conclusions 
A cyanobacterial mat sample from Miers Valley in Antarctica was investigated for the presence of 
new oligopeptides. The putative structures of eight microcystins (3–10) containing a position-1 glycine 
were further characterized using a combination of amino acid analysis, chemical derivatization and 
MS/MS. The presence of the rare substitution of the position-1 amino acid for glycine was confirmed 
using amino acid analysis, as was the stereochemistry of several other structural elements (L-Leu, D-Glu, 
D-Asp and 3(S)-Adda). Tandem MS indicated the presence of Har and ADMAdda residues, which are 
uncommon modifications in microcystins. Amino acid analysis and thiol derivatization indicated that 
the position-7 amino acid was Dhb and not Mdha, which is commonly observed in microcystins.  
The micro-scale thiol derivatization technique [28] was invaluable for confirming the identity of the 
position-7 amino acid when dealing with such a small quantity of sample. 
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